AzTrials
AzTrials

Colonic PolypLUTETIA2NCT06550908

Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images

A study testing Lutetia Training Plattform - real images and Lutetia Training Plattform - artifical images in people with Colonic Polyp and Colon Adenoma, run by Wuerzburg University Hospital at 1 site in Germany.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Training in endoscopy is essential for the early detection of precursors of colorectal cancer. Up to now, this training has been carried out with image collections of findings and in practice when working on patients. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Colonic Polyp, Colon Adenoma
What is being tested?
Lutetia Training Plattform - real images and Lutetia Training Plattform - artifical images
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteGermany
Study dates
15 Apr 2025to 31 Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Physicians with or without experience in colonoscopy

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Germany1 site, 1 recruiting
  • University hospital Würzburg

    Würzburg

    Prof. Dr. med. Hann, +49 931 201 45918, hann_a@ukw.de

    Recruiting

Other trials in Germany

About this study

Training in endoscopy is essential for the early detection of precursors of colorectal cancer. Up to now, this training has been carried out with image collections of findings and in practice when working on patients. The investigators want to use artificial intelligence (AI) to better train doctors to recognise these precursors. By using generative AI, the investigators were able to create realistic images that comply with data protection regulations and whose content can be predefined. Parts of the image can also be regenerated so that it is possible to create different precancerous stages in the same place in the image.

In this study the investigators want to train physicians using real images or artificial images in order to compare which version helps classify polyps better.

Being tested
Lutetia Training Plattform - real images, Lutetia Training Plattform - artifical images
Keywords
Colonoscopy
Medical subject headings
Colonic Polyps

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lutetia Training Plattform - real imagesOther

    Training platform Lutetia offers training the Paris classification using real images of colon polyps.

  • Lutetia Training Plattform - artifical imagesOther

    Training platform Lutetia offers training the Paris classification using artificial images of colon polyps.

Study groups in NCT06550908
Study groupRoleWhat they receive
Training with real imagesActive comparatorPhysicians train using the Paris classification with real colon polyp images
Receives: Other: Lutetia Training Plattform - real images
Training with artificial imagesExperimentalPhysicians train using the Paris classification with artificial colon polyp images
Receives: Other: Lutetia Training Plattform - artifical images

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy for Paris classification

    Ability to correctly classify colonic polyps using the Paris classification

    Measured: 9 months

Secondary outcomes (4)
  1. Range of misclassifications for Paris classification

    Number of misclassification categorizes (eg 1-4)

    Measured: 9 months

  2. Influence of endoscopy experience on accuracy for correct Paris classification

    Influence of endoscopy experience measured in number of perfomed colonoscopies on accuracy for correct Paris classification

    Measured: 9 months

  3. Influence of time to complete course on accuracy for correct Paris classification

    Influence of time to complete course measured in days on accuracy for correct Paris classification

    Measured: 9 months

  4. Influence regular usage of Paris classification on accuracy for correct Paris classification

    Influence regular usage of Paris classification (yes/no) on accuracy for correct Paris classification

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2024
  2. Study start15 Apr 2025
  3. Primary completion31 Aug 2025 (estimated)
  4. Study completion31 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06550908
Sponsor's protocol ID
2022120701-2
Acronym
LUTETIA2
Status last verified
Aug 2025
First submitted
8 Aug 2024
Last updated
12 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Lutetia Training Plattform - real images and Lutetia Training Plattform - artifical images in people with Colonic Polyp and Colon Adenoma, run by Wuerzburg University Hospital at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alexander Hann, MD (0049931201 ext. 45918, hann_a@ukw.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy for Paris classification (time frame: 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in